| Product Code: ETC7678031 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Italy Monogenic Disease Testing Market Overview |
3.1 Italy Country Macro Economic Indicators |
3.2 Italy Monogenic Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Italy Monogenic Disease Testing Market - Industry Life Cycle |
3.4 Italy Monogenic Disease Testing Market - Porter's Five Forces |
3.5 Italy Monogenic Disease Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Italy Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Italy Monogenic Disease Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Italy Monogenic Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenic diseases in Italy |
4.2.2 Technological advancements in genetic testing methods |
4.2.3 Rising awareness and adoption of personalized medicine in healthcare |
4.3 Market Restraints |
4.3.1 High costs associated with genetic testing |
4.3.2 Limited accessibility to advanced genetic testing facilities in certain regions of Italy |
5 Italy Monogenic Disease Testing Market Trends |
6 Italy Monogenic Disease Testing Market, By Types |
6.1 Italy Monogenic Disease Testing Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Italy Monogenic Disease Testing Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Italy Monogenic Disease Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.1.4 Italy Monogenic Disease Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.1.5 Italy Monogenic Disease Testing Market Revenues & Volume, By New-Born Screening, 2021- 2031F |
6.1.6 Italy Monogenic Disease Testing Market Revenues & Volume, By Predictive and Pre-Symptomatic Testing, 2021- 2031F |
6.1.7 Italy Monogenic Disease Testing Market Revenues & Volume, By Prenatal Testing, 2021- 2031F |
6.2 Italy Monogenic Disease Testing Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Italy Monogenic Disease Testing Market Revenues & Volume, By Cystic fibrosis, 2021- 2031F |
6.2.3 Italy Monogenic Disease Testing Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.2.4 Italy Monogenic Disease Testing Market Revenues & Volume, By Severe Combined Immunodeficiency (SCID), 2021- 2031F |
6.2.5 Italy Monogenic Disease Testing Market Revenues & Volume, By Tay-Sachs Disorder, 2021- 2031F |
6.2.6 Italy Monogenic Disease Testing Market Revenues & Volume, By Polycystic Kidney Disorder, 2021- 2031F |
6.2.7 Italy Monogenic Disease Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Italy Monogenic Disease Testing Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Italy Monogenic Disease Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Italy Monogenic Disease Testing Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Italy Monogenic Disease Testing Market Revenues & Volume, By Specialized Clinics, 2021- 2031F |
7 Italy Monogenic Disease Testing Market Import-Export Trade Statistics |
7.1 Italy Monogenic Disease Testing Market Export to Major Countries |
7.2 Italy Monogenic Disease Testing Market Imports from Major Countries |
8 Italy Monogenic Disease Testing Market Key Performance Indicators |
8.1 Average turnaround time for monogenic disease test results |
8.2 Adoption rate of genetic counseling services in relation to monogenic disease testing |
8.3 Number of research and development partnerships for innovative genetic testing technologies in Italy |
9 Italy Monogenic Disease Testing Market - Opportunity Assessment |
9.1 Italy Monogenic Disease Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Italy Monogenic Disease Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Italy Monogenic Disease Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Italy Monogenic Disease Testing Market - Competitive Landscape |
10.1 Italy Monogenic Disease Testing Market Revenue Share, By Companies, 2024 |
10.2 Italy Monogenic Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here